Skip to main content
. 2019 Aug 19;38(20):e101443. doi: 10.15252/embj.2018101443

Table 1.

Top hits of the viability screen comparing HeLa to CCNF K/O using the KCGS

Compound name Δ z‐score Target
100 nM
More sensitive
C10 VE‐822 −0.61484 ATR
B17 CCT251545 −0.56548 CDK8, CDK19
I03 GSK2336394 −0.4252 PIK3CB
Less sensitive
A20 GW784752X 1.016439 GSK3b
A21 GW580509X 1.052113 VEGFR2
E22 GW296115X 1.443446 PDGFR
1 μM
More sensitive
B08 CCT244747 −2.88143 CHK1
E16 BI00614644 −0.56505 MAPKAPK2, MAPKAPK5, PIM3, PHKG2
I05 SB‐725317 −0.55738 CDK2/cyclinA, LTK
Less sensitive
C11 SB‐590885 1.036447 B‐raf
B03 JNK‐IN‐7 1.164645 JNK
E22 GW296115X 1.180556 PDGFRB
D15 GW814408X 1.364238 GSK3b
H16 GSK1070916 1.572064 Aurora kinase
D12 CA93.0 2.072805 GAK1
10 μM
More sensitive
H19 GW807982X −1.06323 GSK3b
I20 TPKI‐39 −0.86181 CIT, KIT, PDGFRB, CSF1R, PDGFRA, DDR1, FLT1, TIE2
C13 GSK1838705 −0.73301 IGF1R, IR
Less sensitive
G14 PFE‐PKIS 3 0.838916 TNK2, TYRO3, YES, FGFR1,2,&3
H11 CCT241533 0.859239 CHK2
G09 GW440135 0.866643 KIT, NEK7, MEK5, PDGFRB, VEGFR2, NEK9, PDGFRA, FLT4